Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1016/s1875-5364(21)60042-0
|View full text |Cite
|
Sign up to set email alerts
|

Esculetin protects against early sepsis via attenuating inflammation by inhibiting NF-κB and STAT1/STAT3 signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 32 publications
0
10
0
Order By: Relevance
“…In response to LPS stimulation, esculetin downregulates the phosphorylation of IKKα and IκBα. It also inhibits the JMJD3 phosphorylation, thus exhibiting anti-inflammatory properties [44]. Previous findings revealed that esculetin inhibits the nuclear translocation of NFκB by downregulating the LPS-mediated IκBα degradation, thus inhibiting inflammation [45].…”
Section: Esculetin In Inflammationmentioning
confidence: 99%
“…In response to LPS stimulation, esculetin downregulates the phosphorylation of IKKα and IκBα. It also inhibits the JMJD3 phosphorylation, thus exhibiting anti-inflammatory properties [44]. Previous findings revealed that esculetin inhibits the nuclear translocation of NFκB by downregulating the LPS-mediated IκBα degradation, thus inhibiting inflammation [45].…”
Section: Esculetin In Inflammationmentioning
confidence: 99%
“…In addition, the translocation of p65 from the cytoplasm to the nucleus was also inhibited upon esculetin treatment in macrophages. The phosphorylation of IKKα/β, IKBα, ERK1/2, JNK, and JMJD3 was also observed to downregulate in esculetin-treated LPS-induced macrophage cells [ 67 ]. Esculetin with a 12 µg/mL dose potentially inhibits the TNF-α, IL-1β, ROS, and LPS-mediated nuclear translocation of NF-κB p65 by suppressing the IKβ-degradation in RAW 264.7 cells [ 68 ].…”
Section: Therapeutic Applications Of Esculetinmentioning
confidence: 99%
“…A broad range of inflammatory or oxidative conditions have been shown to be impacted by esculetin. These include lung injury and fibrosis ( 356 , 357 , 520 ); fibromyalgia ( 521 ); neuronal oxidative stress ( 522 ); psoriasis ( 523 ); arthritis ( 358 ); nociception ( 359 ); colitis ( 360 ); allergy, immunity, and asthma ( 282 , 354 , 380 383 ); and sepsis ( 361 ). The effects of esculetin on numerous cancer cell types have been extensively studied ( 94 , 321 342 , 519 , 524 , 525 ) and are the basis for efforts to develop novel therapeutics ( 98 , 341 ).…”
Section: Effects Of Bioactive Compounds Found In a Scopariamentioning
confidence: 99%